AME vs ROP Stock Comparison: AI Score, Valuation, Performance and Upside
AME (AMETEK) and ROP (Roper Technologies) are two elite industrial technology compounders with exceptional capital allocation track records — AMETEK as the niche electronic instruments and electromechanical devices leader, and Roper as a hybrid industrial-software company increasingly weighted toward high-retention vertical software acquisitions.
AME vs ROP pits two premium capital allocation compounders against each other — AMETEK's precision instruments acquisition machine versus Roper's strategic pivot toward niche vertical software businesses.
AME holds the edge across 3 of 5 key metrics in this comparison. AME has delivered stronger 1-year price return (+19.69% vs +7.48%), though ROP has the better forward P/E setup (17.54x vs 25.23x for AME). On fundamentals, AME is growing revenue faster (15.00%), while ROP maintains the higher operating margin (27.73%) — a classic growth-versus-profitability split. Analyst consensus implies meaningfully more upside for AME (+15.08%) than for ROP (+4.46%).
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
- Want a proven industrial technology compounder with exceptional acquisition integration and niche instrumentation dominance
- Value AMETEK's aerospace, defense, and medical instrument exposure with strong aftermarket service recurring revenue
- Prefer a more traditional industrial technology business model over Roper's hybrid software transition story
- Want an industrial compounder increasingly weighted toward high-retention vertical software businesses with recurring revenue
- Value Roper's exceptional free cash flow conversion providing capital for high-ROIC niche software acquisitions
- See the software business model transition as increasing earnings quality, predictability, and growth sustainability
| Metric | AME | ROP |
|---|---|---|
| AI scorei | 54.5 | 48.5 |
| AI ranki | #270 | #636 |
| Latest closei | $241.91 | $479.54 |
| 1M returni | -3.98% | +35.34% |
| 3M returni | -0.76% | +22.15% |
| 6M returni | +4.98% | +34.99% |
| 1Y returni | +19.69% | +7.48% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | AME | ROP |
|---|---|---|
| 1Y ago | $12.17K (+21.7%) started 2025-11-03 | $10.69K (+6.9%) started 2025-11-03 |
| 5Y ago | $17.97K (+79.7%) started 2021-11-03 | $10.44K (+4.4%) started 2021-11-03 |
| 10Y ago | $61.34K (+513.4%) started 2016-11-03 | $31.1K (+211.0%) started 2016-11-03 |
Hypothetical — past performance does not guarantee future results.
| Metric | AME | ROP |
|---|---|---|
| Market capi | $55.45B | $42.15B |
| Trailing P/Ei | 35.36 | 17.76 |
| Forward P/Ei | 25.23 | 17.54 |
| Price/Salesi | N/A | 8.51 |
| EV/Revenuei | 7.28 | 6.41 |
| Analyst targeti | $278.33 | $445.20 |
| Target upsidei | +15.08% | +4.46% |
| Metric | AME | ROP |
|---|---|---|
| Revenue growthi | 15.00% | 8.50% |
| Earnings growthi | 14.20% | 233.00% |
| EPS growthi | +14.20% | +233.00% |
| FCF margini | +18.98% | +27.36% |
| Operating margini | 26.18% | 27.73% |
| Profit margini | 20.04% | 30.24% |
| ROIC proxyi | 14.56% | 13.07% |
| Return on equityi | 14.56% | 13.07% |
| Dividend yieldi | 0.56% | 0.85% |
| Payout ratioi | 19.01% | 14.46% |
| Dividend growth streaki | No increase yet | No increase yet |
| Betai | 0.99 | 0.74 |
| Debt/equityi | 20.52 | 60.53 |
| Current ratioi | 1.21 | 0.55 |
| Quick ratioi | 0.65 | 0.44 |
Over the past year, AME and ROP have moved weakly in opposite directions (correlation of -0.23), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | AME | ROP |
|---|---|---|---|
| 1Y | Growthi | +21.74% | +6.91% |
| CAGRi | +21.81% | +6.93% | |
| Volatilityi | 22.94% | 31.62% | |
| Sharpe ratioi | 0.79 | 0.23 | |
| Sortino ratioi | 1.14 | 0.33 | |
| Max drawdowni | 13.70% | 30.68% | |
| Current drawdowni | 6.43% | 0.00% | |
| Avg drawdowni | 3.70% | 16.34% | |
| Ulcer Indexi | 5.01% | 18.77% | |
| Max daily dropi | 4.58% | 9.64% | |
| Max wkly dropi | 7.21% | 11.32% | |
| 5Y | Growthi | +75.53% | +2.28% |
| CAGRi | +11.91% | +0.45% | |
| Volatilityi | 22.17% | 23.34% | |
| Sharpe ratioi | 0.42 | -0.06 | |
| Sortino ratioi | 0.60 | -0.08 | |
| Max drawdowni | 27.06% | 46.79% | |
| Current drawdowni | 6.43% | 19.13% | |
| Avg drawdowni | 6.80% | 13.32% | |
| Ulcer Indexi | 8.96% | 18.56% | |
| Max daily dropi | 8.27% | 9.64% | |
| Max wkly dropi | 11.91% | 12.31% | |
| 10Y | Growthi | +478.45% | +195.70% |
| CAGRi | +19.19% | +11.45% | |
| Volatilityi | 24.60% | 24.12% | |
| Sharpe ratioi | 0.66 | 0.39 | |
| Sortino ratioi | 0.93 | 0.54 | |
| Max drawdowni | 42.72% | 46.79% | |
| Current drawdowni | 6.43% | 19.13% | |
| Avg drawdowni | 5.65% | 9.07% | |
| Ulcer Indexi | 8.25% | 14.04% | |
| Max daily dropi | 16.17% | 10.19% | |
| Max wkly dropi | 24.02% | 17.24% |
| Category | AME | ROP |
|---|---|---|
| Company | AMETEK, Inc. | Roper Technologies, Inc. |
| Sector | Industrials | Technology |
| Industry | Specialty Industrial Machinery | Software - Application |
| Core business | AMETEK is a leading manufacturer of electronic instruments and electromechanical devices for aerospace, defense, medical, industrial, and power markets, generating durable margins through precision instruments and specialty materials with significant aftermarket service revenue. | Roper Technologies is a diversified industrial technology company operating vertically-focused software businesses (healthcare IT, legal, engineering software) alongside industrial systems businesses, with an explicit strategy of acquiring niche, high-retention software businesses. |
| Investor focus | Investors track AMETEK's organic revenue growth, EBITDA margins in the 23-25%+ range, consistent acquisition integration track record, and EPS growth compound rate as a quality industrial compounder. | Investors track Roper's organic revenue and ARR growth across its software businesses, free cash flow conversion above 100% of net income, and M&A pipeline as it deploys capital into high-ROIC niche software acquisitions. |
- Exceptional acquisition and integration discipline — AMETEK has compounded earnings through disciplined bolt-on acquisitions for decades
- Highly differentiated niche instruments for aerospace, defense, and medical applications have strong competitive moats from precision and regulatory qualification
- Aftermarket parts and service revenue provides recurring, high-margin revenue alongside new equipment sales
- Vertically-focused software acquisitions (healthcare credentialing, legal billing, engineering workflow) have near-100% retention and minimal competition given deep customer integration
- Exceptional free cash flow conversion — software businesses require minimal capital reinvestment, generating cash for further acquisitions
- Roper's software transition has shifted the business toward higher-quality recurring revenue from mission-critical vertical applications
- Defense and aerospace cycles can create lumpiness in revenue growth despite the portfolio's diversification
- Acquisition multiples in the specialty industrial space have increased significantly, potentially reducing future deal returns
- Integration of larger acquisitions requires careful management to maintain AMETEK's historically strong operating margins
- Industrial segment revenue is cyclical with capital expenditure in the markets it serves
- Roper's software valuations may be challenged if software multiples compress in valuation-sensitive rate environments
- Integration discipline across diverse software businesses requires careful management of multiple niche verticals simultaneously
Compare more than two at a time
This page is a fixed writeup on AME and ROP. Our comparison engine is the interactive version: load up to five tickers, switch timeframes, and get the correlation, drawdown, and overlap analysis that a static page can't show.
Add three more names beside AME and ROP, mixing stocks and ETFs in the same table — useful when the real question is which of a whole peer group to own.
AI score, forward P/E, analyst target upside, operating margin, and revenue growth are scored head-to-head, with a running tally of which ticker leads on how many metrics.
Volatility, Sharpe and Sortino ratios, maximum, current, and average drawdown, Ulcer Index, and worst single-day and single-week drops across every timeframe.
Pairwise daily-return correlation for every combination, so you can see whether two holdings actually diversify each other or just move together.
A scatter plot of forward P/E against return on equity, plus drawdown and 30-day rolling volatility charts, to separate what is cheap from what is merely beaten down.
For ETFs, a top-holdings comparison that exposes hidden overlap between funds. Every comparison exports to CSV for your own spreadsheet work.
Two comparisons a week are free without an account. A 14-day trial removes the limit and adds AI price forecasts, stock rankings, saved watchlists, and the intrinsic value calculator — no credit card required.
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.
Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.